« Previous
Next »
Titles
- Concerns about opioid use in Medicare Part D in the Appalachian region1
- Consideration of uncertainty in making benefit-risk determinations in medical device premarket approvals, de novo classifications, and humanitarian device exemptions: guidance for industry and Food and Drug Administration staff1
- Considerations for the development of dried plasma products intended for transfusion1
- Considerations for the inclusion of adolescent patients in adult oncology clinical trials1
- Considerations in demonstrating interchangeability with a reference product1
- Contraceptive access, choice, and utilization: a survey of Mississippi women1
- Contributors to post-injury mental health in urban black men with serious injuries1
- Coordinated development of antimicrobial drugs and antimicrobial susceptibility test devices: guidance for industry and Food and Drug Administration staff1
- Cost savings1
- Course corrections: how health care innovators learn from setbacks to achieve success1